What if cervical cancer detection worked like a pregnancy test?
ScreenHER is advancing early detection for cervical cancer with a rapid, non-invasive test designed to identify precancer and cancer—in minutes.
Same accuracy. real answers.
Image shown is a rendering.
Nearly 50% of cervical cancer cases occur in women who are under- or never-screened.
Screening discomfort, clinic dependence, and long gaps delay diagnosis and treatment.
Introducing
Screenher™
Advancing Early Detection
Same-visit, non-invasive cervical screening at the point of care.
Designed for clinics today—scalable to reach women beyond traditional screening pathways.
Why Now:
Healthcare has shifted. Screening has not.
- Diagnostics are shifting toward decentralized, patient-friendly models
- Post-COVID acceptance of point-of-care testing has accelerated
- Public health and payers are prioritizing prevention over late-stage care
- Women’s health is receiving increased focused — yet remains underserved
- Point-of-care diagnostics are clinically accepted
- Global health leaders have prioritized eliminating cervical cancer
The tools must now match that urgency.
Technology:
ScreenHER is developing a high-sensitivity, point-of-care diagnostic platform designed to identify cervical precancerous and cancer signals in a simple, rapid format.
Mission:
Our mission is to improve women’s lives by enabling earlier cancer detection and an improved screening experience.
Stay informed
Enter your email address to stay up to date on the latest ScreenHER news.
Leadership
Jennifer estep
Founder and CEO
Jennifer is a Purdue-trained mechanical engineer and experienced medtech commercialization leader who has scaled venture-backed medical device platforms from early development through IPO-ready growth.
She founded ScreenHER to bring patient-centered design, operational rigor, and real-world scalability to women’s health diagnostics—advancing earlier detection and expanding access to preventive care globally.
